Skip to main content
SpringerLink
Log in

Reporting of Prostate Biopsy

  • Chapter
  • First Online:
Prostate Biopsy Interpretation: An Illustrated Guide

  • 1908 Accesses

Abstract

The primary goal of prostate needle biopsy is to diagnose prostate cancer (PCa). Biopsy evaluation also provides a significant quantity of important data, including histological type, Gleason score, and tumor volume and extent, which are all critical for clinicians to prognosticate and manage patients. In keeping with the current trend of standardization of surgical pathology reports [1–3], several pathology organizations periodically issue recommendations for the reporting of prostate cancer in needle biopsy specimens [4]. The information that must be included in prostate biopsy reports is understandably in flux as our understanding of the pathological and molecular characteristics of prostate cancer expands, and diagnosis and treatment of prostate cancer continue to evolve. In addition, the prostate biopsy report should be written in a way that facilitates effective communications between pathologists and clinicians.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Epstein JI, Srigley J, Grignon D, Humphrey P (2007) Recommendations for the reporting of prostate carcinoma. Hum Pathol 38:1305–1309

    Article  PubMed  Google Scholar 

  2. Epstein JI, Srigley J, Grignon D, Humphrey P (2008) Recommendations for the reporting of prostate carcinoma: Association of Directors of Anatomic and Surgical Pathology. Am J Clin Pathol 129:24–30

    Article  PubMed  Google Scholar 

  3. Epstein JI, Srigley J, Grignon D et al (2007) Recommendations for the reporting of prostate carcinoma. Virchows Arch 451:751–756

    Article  PubMed  Google Scholar 

  4. Amin M, Boccon-Gibod L, Egevad L et al (2005) Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimens. Scand J Urol Nephrol Suppl 216:20–33

    Article  PubMed  Google Scholar 

  5. Viglione MP, Potter S, Partin AW et al (2002) Should the diagnosis of benign prostatic hyperplasia be made on prostate needle biopsy? Hum Pathol 33:796–800

    Article  PubMed  Google Scholar 

  6. Rubin MA, Bismar TA, Curtis S, Montie JE (2004) Prostate needle biopsy reporting: how are the surgical members of the Society of Urologic Oncology using pathology reports to guide treatment of prostate cancer patients? Am J Surg Pathol 28:946–952

    Article  PubMed  Google Scholar 

  7. Merrimen JL, Jones G, Walker D et al (2009) Multifocal high grade prostatic intraepithelial neoplasia is a significant risk factor for prostatic adenocarcinoma. J Urol 182:485–490; discussion 490

    Article  PubMed  Google Scholar 

  8. Netto GJ, Epstein JI (2006) Widespread high-grade prostatic intraepithelial neoplasia on prostatic needle biopsy: a significant likelihood of subsequently diagnosed adenocarcinoma. Am J Surg Pathol 30:1184–1188

    Article  PubMed  Google Scholar 

  9. Badalament RA, Miller MC, Peller PA et al (1996) An algorithm for predicting nonorgan confined prostate cancer using the results obtained from sextant core biopsies with prostate specific antigen level. J Urol 156:1375–1380

    Article  PubMed  CAS  Google Scholar 

  10. Freedland SJ, Aronson WJ, Terris MK et al (2003) The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Cancer 98:2344–2350

    Article  PubMed  Google Scholar 

  11. Koh H, Kattan MW, Scardino PT et al (2003) A nomogram to predict seminal vesicle invasion by the extent and location of cancer in systematic biopsy results. J Urol 170:1203–1208

    Article  PubMed  Google Scholar 

  12. Naya Y, Slaton JW, Troncoso P et al (2004) Tumor length and location of cancer on biopsy predict for side specific extraprostatic cancer extension. J Urol 171:1093–1097

    Article  PubMed  Google Scholar 

  13. Hansel DE, Epstein JI (2006) Sarcomatoid carcinoma of the prostate: a study of 42 cases. Am J Surg Pathol 30:1316–1321

    Article  PubMed  Google Scholar 

  14. Lane BR, Magi-Galluzzi C, Reuther AM et al (2006) Mucinous adenocarcinoma of the prostate does not confer poor prognosis. Urology 68:825–830

    Article  PubMed  Google Scholar 

  15. Mazzucchelli R, Morichetti D, Lopez-Beltran A et al (2009) Neuroendocrine tumours of the urinary system and male genital organs: clinical significance. BJU Int 103:1464–1470

    Article  PubMed  Google Scholar 

  16. Osunkoya AO, Nielsen ME, Epstein JI (2008) Prognosis of mucinous adenocarcinoma of the prostate treated by radical prostatectomy: a study of 47 cases. Am J Surg Pathol 32:468–472

    Article  PubMed  Google Scholar 

  17. Parwani AV, Kronz JD, Genega EM et al (2004) Prostate carcinoma with squamous differentiation: an analysis of 33 cases. Am J Surg Pathol 28:651–657

    Article  PubMed  Google Scholar 

  18. Samaratunga H, Delahunt B (2008) Ductal adenocarcinoma of the prostate: current opinion and controversies. Anal Quant Cytol Histol 30:237–246

    PubMed  Google Scholar 

  19. D’Amico AV, Renshaw AA, Cote K et al (2004) Impact of the percentage of positive prostate cores on prostate cancer-specific mortality for patients with low or favorable intermediate-risk disease. J Clin Oncol 22:3726–3732

    Article  PubMed  Google Scholar 

  20. Maygarden SJ, Pruthi R (2005) Gleason grading and volume estimation in prostate needle biopsy specimens: evolving issues. Am J Clin Pathol 123:S58–S66

    PubMed  Google Scholar 

  21. Rossi PJ, Clark PE, Papagikos MA et al (2006) Percentage of positive biopsies associated with freedom from biochemical recurrence after low-dose-rate prostate brachytherapy alone for clinically localized prostate cancer. Urology 67:349–353

    Article  PubMed  Google Scholar 

  22. Miller JS, Chen Y, Ye H et al (2010) Extraprostatic extension of prostatic adenocarcinoma on needle core biopsy: report of 72 cases with clinical follow-up. BJU Int 106:330–333

    Article  PubMed  Google Scholar 

  23. Ye H, Walsh PC, Epstein JI (2010) Skeletal muscle involvement by limited Gleason score 6 adenocarcinoma of the prostate on needle biopsy is not associated with adverse findings at radical prostatectomy. J Urol 184:2308–2312

    Article  PubMed  Google Scholar 

  24. Stone NN, Stock RG, Parikh D et al (1998) Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate. J Urol 160:1722–1726

    Article  PubMed  CAS  Google Scholar 

  25. Vallancien G, Bochereau G, Wetzel O et al (1994) Influence of preoperative positive seminal vesicle biopsy on the staging of prostatic cancer. J Urol 152:1152–1156

    PubMed  CAS  Google Scholar 

  26. Harnden P, Shelley MD, Clements H et al (2007) The prognostic significance of perineural invasion in prostatic cancer biopsies: a systematic review. Cancer 109:13–24

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Urologic Pathology, Caris Life Sciences, 6655 North MacArthur Boulevard, Irving, Texas, 75039, USA

    Rajal B. Shah M.D. (Director)

  2. New York University, 550 First Avenue, New York, NY, 10016, USA

    Ming Zhou M.D., Ph.D. (Associate Professor Director of Surgical Pathology, Tisch Hospital Director of Genitourinary Pathology, Tisch Hospital)

Authors
  1. Rajal B. Shah M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ming Zhou M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rajal B. Shah M.D. .

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Shah, R.B., Zhou, M. (2012). Reporting of Prostate Biopsy. In: Prostate Biopsy Interpretation: An Illustrated Guide. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-21369-4_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-21369-4_15

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-21368-7

  • Online ISBN: 978-3-642-21369-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation